Cepazine
CAS No. 64544-07-6
Cepazine ( Cefuroxime axetil; SN 407; DRG-0157; CXM-AX )
Catalog No. M15451 CAS No. 64544-07-6
Cefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 as Zinnat.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 32 | In Stock |
|
25MG | 68 | In Stock |
|
50MG | 115 | In Stock |
|
100MG | 178 | In Stock |
|
500MG | 462 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCepazine
-
NoteResearch use only, not for human use.
-
Brief DescriptionCefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 as Zinnat.
-
DescriptionCefuroxime axetil is a second generation oral cephalosporin antibiotic. It was discovered by Glaxo now GlaxoSmithKline and introduced in 1987 as Zinnat.
-
SynonymsCefuroxime axetil; SN 407; DRG-0157; CXM-AX
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number64544-07-6
-
Formula Weight510.47
-
Molecular FormulaC20H22N4O10S
-
Purity>98%(HPLC)
-
SolubilitySoluble in Water
-
SMILESO=C(C(N12)=C(COC(N)=O)CS[C@]2([H])[C@H](NC(/C(C3=CC=CO3)=N\OC)=O)C1=O)OC(OC(C)=O)C
-
Chemical Name5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, 1-(acetyloxy)ethyl ester, (6R-(6alpha,7beta(Z)))-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Singh B, et al. Colloids Surf B Biointerfaces. 2014 Sep 1;121:92-8.
molnova catalog
related products
-
Etretinate
Etretinate is a RAR and RXR agonist previoulsy used to treat psoriasis. It induces brth defects and suppresses proliferation in cutaneous T-cell lymphoma models.
-
SPHINX
SPHINX is a new generation inhibitor of SPRK1.
-
Diroximel Fumarete
Diroximel fumarate, a prodrug of monomethyl fumarate in a controlled-release formulation, rapidly and potently converts to MMF in the body.